Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Nash

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Uncovering and engineering the mechanical properties of the adhesion GPCR ADGRG1 GAIN domainL Dumas, M Marfoglia, B Yang, et al.
Human Gene Therapy|November 1, 1995
Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vectorM A Nash, C D Platsoucas, B Y Wong, et al.
Clinical and Experimental Immunology|July 2, 1998
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell linesM A Nash, R Lenzi, C L Edwards, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Molecular characterization of an adhesion GPCR signal transductionM Marfoglia, L Dumas, B S Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinomaM E Gordinier, H Z Zhang, R Patenia, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaR S Freedman, J A Gibbons, M Giedlin, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Uncovering and engineering the mechanical properties of the adhesion GPCR ADGRG1 GAIN domainL Dumas, M Marfoglia, B Yang, et al.
Human Gene Therapy|November 1, 1995
Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vectorM A Nash, C D Platsoucas, B Y Wong, et al.
Clinical and Experimental Immunology|July 2, 1998
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell linesM A Nash, R Lenzi, C L Edwards, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Molecular characterization of an adhesion GPCR signal transductionM Marfoglia, L Dumas, B S Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinomaM E Gordinier, H Z Zhang, R Patenia, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaR S Freedman, J A Gibbons, M Giedlin, et al.
Pageof 3